Sleep Aids (Pharmacies) - Cyprus

  • Cyprus
  • Revenue in the Sleep Aids market is projected to reach US$206.80k in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.20%, resulting in a market volume of US$208.50k by 2028.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.16 are generated in 2024.

Key regions: South Korea, Japan, Canada, France, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in Cyprus has been experiencing steady growth in recent years, driven by changing customer preferences, market trends, and local special circumstances.

Customer preferences:
Customers in Cyprus are increasingly seeking sleep aids to address their sleep-related issues. This is partly due to the rising awareness about the importance of sleep for overall health and well-being. Additionally, the high-stress lifestyles and demanding work schedules of individuals in Cyprus have contributed to a growing demand for sleep aids. Customers are looking for effective and convenient solutions to help them improve their sleep quality and duration.

Trends in the market:
One major trend in the Sleep Aids (Pharmacies) market in Cyprus is the increasing popularity of natural and herbal sleep aids. Customers are becoming more conscious about the potential side effects of pharmaceutical sleep aids and are opting for natural alternatives. This trend is in line with the global market, where natural sleep aids are gaining traction. Manufacturers and retailers in Cyprus are responding to this trend by introducing a wider range of natural sleep aids, including herbal supplements and aromatherapy products. Another trend in the market is the growing availability of sleep aids online. Customers in Cyprus are increasingly turning to online platforms to purchase sleep aids due to the convenience and accessibility they offer. This trend has been further accelerated by the COVID-19 pandemic, which has led to an increase in online shopping across various sectors. Pharmacies in Cyprus are adapting to this trend by expanding their online presence and offering a seamless shopping experience to their customers.

Local special circumstances:
Cyprus is a popular tourist destination, attracting millions of visitors each year. The tourism industry plays a significant role in the country's economy, and the influx of tourists has a direct impact on the Sleep Aids (Pharmacies) market. Tourists often experience jet lag or have difficulty adjusting to a new environment, leading to sleep disturbances. As a result, there is a higher demand for sleep aids in tourist areas, leading to increased sales for pharmacies in these regions.

Underlying macroeconomic factors:
The overall economic stability and disposable income levels in Cyprus also contribute to the growth of the Sleep Aids (Pharmacies) market. As the economy continues to recover from the financial crisis of 2013, consumers have more purchasing power, allowing them to spend on sleep aids. Additionally, the aging population in Cyprus is also a key driver of the market, as older individuals are more likely to experience sleep-related issues and seek sleep aids to improve their sleep quality. In conclusion, the Sleep Aids (Pharmacies) market in Cyprus is developing due to changing customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The increasing demand for natural sleep aids, the rise of online shopping, the impact of tourism, and the country's economic stability all contribute to the growth of the market. Pharmacies in Cyprus are adapting to these trends and special circumstances to meet the evolving needs of their customers.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)